{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:32:54Z","timestamp":1793363574918,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T00:00:00Z","timestamp":1664409600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018556","name":"Voyager Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018556","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000861","name":"Burroughs Wellcome Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000861","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006691","name":"Harvard Medical School","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007886","name":"Dana-Farber Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007886","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013117","name":"International Fibrodysplasia Ossificans Progressiva Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013117","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014276","name":"Pershing Square Sohn Cancer Research Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014276","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01AR078230"],"award-info":[{"award-number":["R01AR078230"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R21AR077557"],"award-info":[{"award-number":["R21AR077557"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01AI100263"],"award-info":[{"award-number":["P01AI100263"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01HD080642"],"award-info":[{"award-number":["P01HD080642"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI12135"],"award-info":[{"award-number":["R01AI12135"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS076991"],"award-info":[{"award-number":["R01NS076991"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.ymthe.2022.09.018","type":"journal-article","created":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T03:06:03Z","timestamp":1664766363000},"page":"435-453","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"title":["WNT-modulating gene silencers as a gene therapy for osteoporosis, bone fracture, and critical-sized bone defects"],"prefix":"10.1016","volume":"31","author":[{"given":"Won-Taek","family":"Oh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeon-Suk","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Min","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwang-Hwan","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel S.","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung-Hyun","family":"Park-Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew B.","family":"Greenblatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangping","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Hyuck","family":"Shim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2022.09.018_bib1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/1759720X16670154","article-title":"Bone modeling and remodeling: potential as therapeutic targets for the treatment of osteoporosis","volume":"8","author":"Langdahl","year":"2016","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"key":"10.1016\/j.ymthe.2022.09.018_bib2","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/jbmr.251","article-title":"Effects of denosumab on bone turnover markers in postmenopausal osteoporosis","volume":"26","author":"Eastell","year":"2011","journal-title":"J.\u00a0Bone Miner Res."},{"key":"10.1016\/j.ymthe.2022.09.018_bib3","doi-asserted-by":"crossref","first-page":"471035","DOI":"10.1155\/2014\/471035","article-title":"Bisphosphonate associated osteonecrosis of the jaw: an update on pathophysiology, risk factors, and treatment","volume":"2014","author":"Rasmusson","year":"2014","journal-title":"Int. J. Dent"},{"key":"10.1016\/j.ymthe.2022.09.018_bib4","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1359\/jbmr.081113","article-title":"Comparison of effects of the bisphosphonate alendronate versus the RANKL inhibitor denosumab on murine fracture healing","volume":"24","author":"Gerstenfeld","year":"2009","journal-title":"J.\u00a0Bone Miner Res."},{"key":"10.1016\/j.ymthe.2022.09.018_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20010083","article-title":"Anabolic therapies in osteoporosis and bone regeneration","volume":"20","author":"Russow","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2022.09.018_bib6","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s11914-013-0171-2","article-title":"Parathyroid hormone and parathyroid hormone-related protein analogs as therapies for osteoporosis","volume":"11","author":"Augustine","year":"2013","journal-title":"Curr. Osteoporos. Rep."},{"key":"10.1016\/j.ymthe.2022.09.018_bib7","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.bcp.2013.03.002","article-title":"Current perspectives on parathyroid hormone (PTH) and PTH-related protein (PTHrP) as bone anabolic therapies","volume":"85","author":"Esbrit","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ymthe.2022.09.018_bib8","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nrendo.2011.108","article-title":"Parathyroid hormone analogues in the treatment of osteoporosis","volume":"7","author":"Kraenzlin","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.ymthe.2022.09.018_bib9","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/s41574-018-0087-0","article-title":"Clinical advantages and disadvantages of anabolic bone therapies targeting the WNT pathway","volume":"14","author":"Appelman-Dijkstra","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.ymthe.2022.09.018_bib10","doi-asserted-by":"crossref","first-page":"R167","DOI":"10.1530\/JME-18-0176","article-title":"Novel actions of sclerostin on bone","volume":"62","author":"Holdsworth","year":"2019","journal-title":"J.\u00a0Mol. Endocrinol."},{"key":"10.1016\/j.ymthe.2022.09.018_bib11","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1056\/NEJMoa1305224","article-title":"Romosozumab in postmenopausal women with low bone mineral density","volume":"370","author":"McClung","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2022.09.018_bib12","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay6570","article-title":"Evaluating the cardiovascular safety of sclerostin inhibition using evidence from meta-analysis of clinical trials and human genetics","volume":"12","author":"Bovijn","year":"2020","journal-title":"Sci. Transl Med."},{"key":"10.1016\/j.ymthe.2022.09.018_bib13","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.1172\/JCI69443","article-title":"Schnurri-3 regulates ERK downstream of WNT signaling in osteoblasts","volume":"123","author":"Shim","year":"2013","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2022.09.018_bib14","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1126\/science.1126313","article-title":"Regulation of adult bone mass by the zinc finger adapter protein Schnurri-3","volume":"312","author":"Jones","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2022.09.018_bib15","doi-asserted-by":"crossref","first-page":"8173","DOI":"10.1073\/pnas.1205848109","article-title":"Control of bone resorption in mice by Schnurri-3","volume":"109","author":"Wein","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2022.09.018_bib16","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/s41591-018-0020-z","article-title":"Targeting skeletal endothelium to ameliorate bone loss","volume":"24","author":"Xu","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2022.09.018_bib17","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1038\/s41467-019-10809-6","article-title":"Bone-targeting AAV-mediated silencing of Schnurri-3 prevents bone loss in osteoporosis","volume":"10","author":"Yang","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2022.09.018_bib18","doi-asserted-by":"crossref","first-page":"e10226","DOI":"10.1002\/jbm4.10226","article-title":"Biomechanical and bone material properties of schnurri-3 Null mice","volume":"3","author":"Hofstaetter","year":"2019","journal-title":"JBMR Plus"},{"key":"10.1016\/j.ymthe.2022.09.018_bib19","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41392-021-00487-6","article-title":"Viral vector platforms within the gene therapy landscape","volume":"6","author":"Bulcha","year":"2021","journal-title":"Signal Transduct Target Ther."},{"key":"10.1016\/j.ymthe.2022.09.018_bib20","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","article-title":"Adeno-associated virus vector as a platform for gene therapy delivery","volume":"18","author":"Wang","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymthe.2022.09.018_bib21","first-page":"6217286","article-title":"Sclerostin antibody therapy for the treatment of osteoporosis: clinical Prospects and Challenges","volume":"2016","author":"MacNabb","year":"2016","journal-title":"J.\u00a0Osteoporos."},{"key":"10.1016\/j.ymthe.2022.09.018_bib22","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nrendo.2013.154","article-title":"Wnt signalling in osteoporosis: mechanisms and novel therapeutic approaches","volume":"9","author":"Canalis","year":"2013","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.ymthe.2022.09.018_bib23","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.omtm.2020.04.010","article-title":"Bone-targeting AAV-mediated gene silencing in osteoclasts for osteoporosis therapy","volume":"17","author":"Yang","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2022.09.018_bib24","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nature04791","article-title":"Fatality in mice due to oversaturation of cellular microRNA\/short hairpin RNA pathways","volume":"441","author":"Grimm","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2022.09.018_bib25","doi-asserted-by":"crossref","first-page":"5868","DOI":"10.1073\/pnas.0801775105","article-title":"Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi","volume":"105","author":"McBride","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2022.09.018_bib26","series-title":"A Novel rAAV-amiRNA Platform Enables Potent in\u00a0Vivo Gene Silencing and a Ten-fold Enhancement of On-Target Specificity over Conventional shRNA Vectors","author":"Xie","year":"2018"},{"key":"10.1016\/j.ymthe.2022.09.018_bib27","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3389\/fgene.2014.00140","article-title":"Redundancy of the genetic code enables translational pausing","volume":"5","author":"D'Onofrio","year":"2014","journal-title":"Front Genet."},{"key":"10.1016\/j.ymthe.2022.09.018_bib28","doi-asserted-by":"crossref","first-page":"16744","DOI":"10.1074\/jbc.M114.628313","article-title":"The Wnt inhibitor sclerostin is up-regulated by mechanical Unloading in osteocytes in\u00a0vitro","volume":"290","author":"Spatz","year":"2015","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2022.09.018_bib29","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/1471-213X-10-121","article-title":"A sensitive and bright single-cell resolution live imaging reporter of Wnt\/ss-catenin signaling in the mouse","volume":"10","author":"Ferrer-Vaquer","year":"2010","journal-title":"BMC Dev. Biol."},{"key":"10.1016\/j.ymthe.2022.09.018_bib30","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.devcel.2005.02.017","article-title":"Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation","volume":"8","author":"Glass","year":"2005","journal-title":"Dev. Cell"},{"key":"10.1016\/j.ymthe.2022.09.018_bib31","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.cell.2007.07.025","article-title":"Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts","volume":"130","author":"Nakamura","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2022.09.018_bib32","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1359\/JBMR.050307","article-title":"Ovariectomy-induced bone loss varies among inbred strains of mice","volume":"20","author":"Bouxsein","year":"2005","journal-title":"J.\u00a0Bone Miner Res."},{"key":"10.1016\/j.ymthe.2022.09.018_bib33","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.injury.2020.10.050","article-title":"The relation between fracture activity and bone healing with special reference to the early healing phase - a preclinical study","volume":"52","author":"Windolf","year":"2021","journal-title":"Injury"},{"key":"10.1016\/j.ymthe.2022.09.018_bib34","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/term.1655","article-title":"A uni-cortical femoral defect model in the rat: evaluation using injectable hyaluronan hydrogel as a carrier for bone morphogenetic protein-2","volume":"9","author":"Hulsart-Billstrom","year":"2015","journal-title":"J.\u00a0Tissue Eng. Regen. Med."},{"key":"10.1016\/j.ymthe.2022.09.018_bib35","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1038\/s41598-017-02705-0","article-title":"An appropriate Wnt\/beta-catenin expression level during the remodeling phase is required for improved bone fracture healing in mice","volume":"7","author":"Bao","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2022.09.018_bib36","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/BOT.0000000000001420","article-title":"Autograft, allograft, and bone graft Substitutes: clinical evidence and indications for Use in the setting of Orthopaedic Trauma surgery","volume":"33","author":"Baldwin","year":"2019","journal-title":"J.\u00a0Orthop. Trauma"},{"key":"10.1016\/j.ymthe.2022.09.018_bib37","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nm.2617","article-title":"A delivery system targeting bone formation surfaces to facilitate RNAi-based anabolic therapy","volume":"18","author":"Zhang","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2022.09.018_bib38","doi-asserted-by":"crossref","first-page":"13971","DOI":"10.1038\/s41598-017-14149-7","article-title":"Evaluation of Ga-DOTA-(D-Asp)n as bone imaging agents: D-aspartic acid peptides as carriers to bone","volume":"7","author":"Ogawa","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2022.09.018_bib39","doi-asserted-by":"crossref","DOI":"10.3791\/52947","article-title":"Distinctive capillary action by Micro-channels in bone-like Templates can enhance Recruitment of cells for Restoration of large bony defect","author":"Oh","year":"2015","journal-title":"J.\u00a0Vis. Exp."},{"key":"10.1016\/j.ymthe.2022.09.018_bib40","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1097-2765(01)00434-8","article-title":"A mammalian homolog of Drosophila schnurri, KRC, regulates TNF receptor-driven responses and interacts with TRAF2","volume":"9","author":"Oukka","year":"2002","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ymthe.2022.09.018_bib41","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nature01660","article-title":"Control of osteoblast function and regulation of bone mass","volume":"423","author":"Harada","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2022.09.018_bib42","article-title":"Recent Progresses in the treatment of osteoporosis","volume":"12","author":"Li","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ymthe.2022.09.018_bib43","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00223-017-0275-2","article-title":"Sclerostin antibody increases callus size and Strength but does not improve fracture union in a challenged open rat fracture model","volume":"101","author":"Morse","year":"2017","journal-title":"Calcif Tissue Int."},{"key":"10.1016\/j.ymthe.2022.09.018_bib44","doi-asserted-by":"crossref","first-page":"13175","DOI":"10.1038\/s41598-018-31345-1","article-title":"Continuous infusion of PTH1-34 delayed fracture healing in mice","volume":"8","author":"Yukata","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2022.09.018_bib45","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1002\/jbmr.2888","article-title":"A Crisis in the treatment of osteoporosis","volume":"31","author":"Khosla","year":"2016","journal-title":"J.\u00a0Bone Miner Res."},{"key":"10.1016\/j.ymthe.2022.09.018_bib46","doi-asserted-by":"crossref","first-page":"11505","DOI":"10.1038\/ncomms11505","article-title":"A bispecific antibody targeting sclerostin and DKK-1 promotes bone mass accrual and fracture repair","volume":"7","author":"Florio","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2022.09.018_bib47","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.ymthe.2017.03.028","article-title":"Short DNA hairpins Compromise recombinant adeno-associated virus genome Homogeneity","volume":"25","author":"Xie","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2022.09.018_bib48","first-page":"1209","article-title":"Introducing genes into mammalian cells: Viral vectors","volume":"2","author":"Gao","year":"2012","journal-title":"Mol. Cloning"},{"key":"10.1016\/j.ymthe.2022.09.018_bib49","doi-asserted-by":"crossref","first-page":"8254","DOI":"10.1073\/pnas.1003727107","article-title":"Uncoupling of growth plate maturation and bone formation in mice lacking both Schnurri-2 and Schnurri-3","volume":"107","author":"Jones","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2022.09.018_bib50","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nature12115","article-title":"Sema3A regulates bone-mass accrual through sensory innervations","volume":"497","author":"Fukuda","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2022.09.018_bib51","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jbmr.5650020617","article-title":"Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee","volume":"2","author":"Parfitt","year":"1987","journal-title":"J.\u00a0Bone Miner Res."},{"key":"10.1016\/j.ymthe.2022.09.018_bib52","doi-asserted-by":"crossref","DOI":"10.1002\/jbmr.3184","article-title":"c-Jun N-terminal kinases (JNKs) are critical mediators of osteoblast activity in\u00a0vivo","author":"Xu","year":"2017","journal-title":"J.\u00a0Bone Miner Res."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001622006074?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001622006074?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:07:01Z","timestamp":1761502021000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001622006074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S1525001622006074"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2022.09.018","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"WNT-modulating gene silencers as a gene therapy for osteoporosis, bone fracture, and critical-sized bone defects","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2022.09.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s).","name":"copyright","label":"Copyright"}]}}